Pulmonary

A Precision Nanomedicine Platform For Pulmonary And Organ Fibrosis

SUMMARY A targeted nanomedicine platform for delivering therapeutics to activated fibroblasts in pulmonary fibrosis and other fibrotic diseases The Unmet Need: Current pulmonary fibrosis therapies slow decline for some patients but do not adequately stop progression, leaving a major need for more effective and better tolerated treatments Pulmonary fibrosis is… Read More

Targeted mRNA Nanomedicine for ARDS and Ventilator-Induced Lung Injury

SUMMARY A targeted nanomedicine platform improves acute respiratory distress syndrome (ARDS) and ventilator-induced lung injury (VILI) outcomes by selectively delivering therapeutic mRNA to inflamed pulmonary microvascular endothelial cells, thereby restoring endothelial function and reducing lung damage. The Unmet Need: Effective treatments for endothelial dysfunction in ARDS and ventilator-induced lung injury… Read More